Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Date and Time: Tuesday 26 July 2022, 2:00 pm (UK BST)

To Join: This is a free event, which will be taking place online via Zoom. To register your interest in attending this talk please click HERE

Abstract: Aaron will be presenting on a diabetes outcomes model using a multi-ethnic, real-world-data cohort of newly diagnosed Type II diabetics. The study used registry data on 150,000 newly diagnosed diabetes patients between 2005 and 2016 with up to 13 years follow-up. The resulting diabetes outcomes model for the US (DOMUS) model integrates separate, but inter-dependent, risk equations to predict a wide range of cardiovascular and non-cardiovascular health events and biomarkers. The model accounts for individual demographics (including race), neighbourhood deprivation, age and a wide range of dynamic clinical and treatment factors. Aaron will discuss the development, challenges, and potential of the DOMUS model and its implications for decisions related to diabetes care and prevention.

Bio: Aaron Winn is an Assistant Professor at the Medical College of Wisconsin. Aaron is a health services researcher whose work focuses on identifying high value medications and making sure that patients have access to medication, particularly vulnerable populations. Aaron has more than 60 peer-reviewed publications. His work has been cited in the popular press including the Washington Post, New York Times, Black Entertainment Television (BET) and by policy makers including the 2016 Economic Report of the President. Aaron received his PhD from the University of North Carolina at Chapel Hill and a Masters of Public Policy from the Harris School of Public Policy at the University of Chicago.